Pain Management

Pain is associated with a variety of injuries and diseases, and is often the disease itself.

The low back, also known as the lumbosacral region, is a complex structure of interconnected and overlapping tendons, ligaments, muscles, nerves, joints, and discs.

The Centers for Disease Control and Prevention estimates that about 2% of the population is affected by fibromyalgia.

Migraines are usually unilateral in nature, with throbbing associated with them and an aura prior to onset, which alerts patients to the migraine.

Pain is a common complaint for which patients elect to use one of the various nonprescription analgesics currently on the market.

The recent explosion in deaths from opioids seems to be different from any previous observations.

Pharmacists can play pivotal roles in pain management, such as counseling patients on properly selecting and using analgesics.

Prescriptions for opioids from the emergency room may be deescalated.

Is there a need to strengthen the labeling of topical NSAIDs that clearly lack systemic therapeutic or toxic levels?

Pharmacists can help minimize risk for patients using pain medications.

Counseling family members about hospice medications requires compassion and empathy.

The FDA approved a 2.9-mg/0.71-mg dosage strength of Orexo's sublingual buprenorphine/naloxone (Zubsolv).

The FDA today approved eluxadoline and rifaximin to treat irritable bowel syndrome with diarrhea.

Chronic pain patients using prescription opioids in conjunction with medical marijuana are not at increased risk for substance abuse.

Regular trips to the emergency department could be a red flag for deadly prescription drug overdose.

Despite advances in pain management and palliative care, intractable cancer pain remains a significant clinical, social, and financial burden in treating the oncologic population.

Deaths related to oxycodone overdose dropped 25% in Florida after the state adopted a Prescription Drug Monitoring Program to track controlled substance dispensing.

The FDA today expanded the indication of Allergan's onabotulinumtoxinA (Botox), allowing the drug to be used for the treatment of upper limb spasticity in adults.

In addition to relieving pain, acetaminophen may cause patients to experience less intense emotional responses.

The FDA is warning pharmacists that pets are at risk of death when exposed to topical pain medications containing flurbiprofen.

Over my past 3 decades of pharmacy practice, acetaminophen has been one of my most recommended OTC treatments.

A pharmacist who posted derogatory comments about a customer on social media is now being investigated by the National Health Service.

Pharmacists are positioned to educate and monitor older patients who are discharged on these medications.

In response to a recent resurgence in fentanyl abuse, the DEA issued a nationwide alert about the dangers of the drug, describing it as a threat to health and public safety.

From optimizing inhaler technique in patients with chronic obstructive pulmonary disease, to catching red flags when dispensing controlled substances to patients with chronic pain, pharmacists can improve patient outcomes in an evolving treatment landscape.

Mylan Inc. has introduced 3 generic versions of existing drugs to the US market, including the first and only available intermediate dosages of transdermal fentanyl.

More than 300 pharmacy students, technicians, and pharmacists helped raise nearly $6500 at the 2015 Mid-Year Conference of the Pennsylvania Pharmacists Association.

I distinctly remember feeling surprised when the FDA approved the first single entity and extended-release hydrocodone pain medication.

Are pharmacists fully aware of the warnings associated with the medications they dispense?